BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,710,445 | -24.7% | 694,821 | -0.1% | 0.27% | -15.1% |
| Q2 2023 | $22,204,793 | +4.3% | 695,421 | 0.0% | 0.32% | +2.6% |
| Q1 2023 | $21,293,791 | -21.9% | 695,421 | -0.2% | 0.31% | -14.6% |
| Q4 2022 | $27,248,758 | +0.0% | 696,721 | +21.9% | 0.36% | -7.4% |
| Q3 2022 | $27,237,000 | +22.9% | 571,721 | -0.2% | 0.39% | +24.9% |
| Q2 2022 | $22,166,000 | -33.6% | 572,621 | -1.8% | 0.31% | -19.3% |
| Q1 2022 | $33,396,000 | -31.6% | 582,821 | -4.9% | 0.39% | -22.9% |
| Q4 2021 | $48,836,000 | -8.4% | 612,821 | 0.0% | 0.50% | -7.0% |
| Q3 2021 | $53,321,000 | -32.4% | 612,821 | 0.0% | 0.54% | -29.7% |
| Q2 2021 | $78,876,000 | +73.9% | 612,821 | +8.1% | 0.77% | +60.4% |
| Q1 2021 | $45,368,000 | +40.0% | 566,821 | +42.8% | 0.48% | +29.4% |
| Q4 2020 | $32,396,000 | – | 396,821 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |